ASTAXANTHIN PLUS - INNOVATIVE BROAD-SPECTRUM DRUGS FROM GREEN ALGAE HAEMATOCOCCUS PLUVIALIS
Purpose of the development:
Represents a therapeutic perspective in the treatment of cardiovascular diseases, cancer, neurological and immune disorders, diabetes, ischemia, Alzheimer's and Parkinson's, as well as to slow down aging.
Recommended application field:
Enterprises of biotechnological and pharmaceutical tutions, medical facilities.
Technical characteristic:
New technology for the preparation of astaxanthin in vegetable oils (sunflower, corn, rice, olive, walnut and grape-seed seed) on the basis of biomass Haematococcus pluvialis, which consists of mixing biomass and oil for 3 hours. Before mixing with the oil biomass is subjected to acid hydrolysis to break the cell wall. Astaxanthin is completely converted into biomass and s oil, and extraction time is reduced by 16 times. This technology provides a rapid transition of astaxanthin, which has a strong lipophilic properties of the oil
Advantages over analogues:
The drug is derived from the primary plant matter, which does not pollute the environment. Has a number of economic advantages, the process is non-toxic, provides expansion of the range of drugs and nutratsevts for pharmacy and medicine.
The development stage readiness:
Ready for application
Description of the development:
() Complex biological product containing astaxanthin derived from biomass of green algae Haematococcus pluvialis for technology oriented marginality extraction of transition and stabilization in a variety of vegetable oils: sunflower, corn, walnut, olive, grape seed oil from the seeds.
Information about newness of the development:
there are Ukrainian patents -- 3 items
corresponds technical description
Ready for implementation
Possibility of transfer abroad:
Licence's sale Technological document's sale Realization of finished commodity
Photo
Country
Moldova
For additional information turn to: E-mail: gal@uintei.kiev.ua
|